Short-read Sequencing Market Global Outlook to 2027 - Genewiz, Genscript Biotech Corporation, Qiagen N.V., Agilent Technologies, BGI Genomics, Fasteris SA
The scale of the read length of a short-read sequencing instrument is between 100 and 600 bp. Short-read sequencing is certainly more economical than long-read sequencing. Targeted DNA sequencing based on short-read sequencing is used as an alternative low-cost solution to detect both known and unknown genetic variants in clinical research samples. DNA sequencing may be used to discover the sequence of individual genes, larger genetic regions (i.e., clusters of genes or operons), full chromosomes, or entire genomes of any organism
Short-read Sequencing Market to 2027 - Global Analysis and Forecasts by Technology (Next-Generation Sequencing, Sanger Sequencing); Product (Instruments, Consumables, Services); Application (Oncology, Clinical Investigation, Reproductive Health, HLA typing/immune system monitoring, Agrigenomics and Forensics, Consumer Genomics); Workflow (Pre-Sequencing, Sequencing, Data Analysis); End User (Academic Research, Clinical Research, Hospitals and Clinics, Pharma and Biotech Companies) and Geography
Get Sample PDF Copy at https://www.theinsightpartners.com/sample/TIPRE00007168?utm_source=OpenPR&utm_medium=Simran
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the short-read sequencing market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The short-read sequencing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting short-read sequencing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the short-read sequencing market in these regions.
The report also includes the profiles of key short-read sequencing market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche AG
- Illumina, Inc.
- Genscript Biotech Corporation
- Qiagen N.V.
- Agilent Technologies
- BGI Genomics
- Fasteris SA
- GE Healthcare
The report covers key developments in the short-read sequencing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from short-read sequencing market are anticipated to have lucrative growth opportunities in the future with the rising demand for short-read sequencing market in the global market. Below mentioned is the list of few companies engaged in the biological safety testing products & services market.
Buy Complete Report at https://www.theinsightpartners.com/buy/TIPRE00007168?utm_source=OpenPR&utm_medium=Simran
Contact us –
Phone : +1-646-491-9876
Email Id : email@example.com
About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Short-read Sequencing Market Global Outlook to 2027 - Genewiz, Genscript Biotech Corporation, Qiagen N.V., Agilent Technologies, BGI Genomics, Fasteris SA here
News-ID: 1862354 • Views: 231
More Releases from The Insight Partners
Artificial Intelligence in Supply Chain Market Outlook to 2027 with Top Key Play …
“Worldwide Artificial Intelligence in Supply Chain Market Analysis 2019-2027″ is a specialized and in-depth study of the technology industry focusing on the global market trend. The report aims to provide an overview of the global Artificial Intelligence in Supply Chain Market with detailed market segmentation by type, application and geography. The global market for Artificial Intelligence in Supply Chain Market is expected to grow strongly in the forecasting period. The
Cognitive Robotic Process Automation Market Future Trends to 2027 - IPsoft, Veri …
According to a new market study entitled "Cognitive Robotic Process Automation Market to 2027 - Global Analysis and Forecasts by Deployment Type (On-Premise and Cloud) and Industry Vertical (BFSI, Healthcare & Life Sciences, Retail & Consumer Goods, Manufacturing, Travel & Hospitality, IT & Telecommunication, Media & Entertainment, and Others) and Geography, "explains the report, explaining the key drivers of this growth and highlighting key market players and their evolution. The
Allergy Immunotherapy Market Competitive Dynamics and Business Outlook 2027 | Ci …
Allergy Immunotherapy Market: Introduction and Dynamics Allergy Immunotherapy Market concludes with precise and authentic market estimations considering all the parameters and market dynamics. Every crucial and decisive detail for the development and restriction of the market is mentioned in the report that may affect the market in near future. Segmentation of the market are studied specifically to give profound knowledge for supplementary market investments. The report aims to provide an overview of
Generic Drugs Market 2019 Statistic Competitive Landscape Forecast to 2027 With …
The “The Insight Partners “ market research report provides a comprehensive picture on “Generic Drugs Market”, from the global viewpoint, offering a forecast and statistic in terms of revenue during the forecast period. The report covers a descriptive analysis with detailed segmentation, complete research and development history, latest news and press releases. Furthermore, the study explains the future opportunities and a sketch of key players operating in the “Generic Drugs
More Releases for Sequencing
Precision Medicine Market Report 2018: Segmentation by Technology (Genomics, Tra …
Global Precision Medicine market research report provides company profile for Abbott Laboratories, Almac Group, Ltd, Asuragen, Inc., Cepheid Inc, Cetics Healthcare Technologies GmbH, Ge Healthcare, Glaxosmithkline Plc, Intomics A/S., Biocrates Life Sciences Ag, Pfizer Inc. and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth
Next Wave in DNA Sequencing Market
Sequencing by synthesis (SBS), is one of the most influential and greatly adopted DNA sequencing technologies used by researchers and scientist globally. This technology offers a massive sequence throughput at modest costs in a single sequencing run. DNA Sequencing Market was valued at $5,156 million in 2016 and is expected to reach $18,284 million in 2023, registering a CAGR of 19.6% from 2017 to 2023. DNA sequencing is a technology in
Next Generation Sequencing Market Global Analysis and Forecasts by Service (Geno …
ReportsWeb.com has announced the addition of the “Next Generation Sequencing Market to 2025”, the report classifies the global Next Generation Sequencing Market in a precise manner to offer unearth valuable, accurate and reliable data insights that help organizations to meet their business objectives and enable growth. The next generation market is estimated to account for US$ 26,501.2 Mn by the end of 2025, escalating at a CAGR of 21.1% during the
Next Generation Sequencing Market By Key Manufacturers (Illumina, Qiagen, Perkin …
Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery. The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical
Pyro Sequencing Market: Business Intelligence & Market Insights
Pyro sequencing is a DNA sequencing technology based on the principle of sequencing-by-synthesis. The method consist of series of four enzymatic steps to detect sequence of nuclei acid during synthesis. Pyro sequencing can be easily automated and provides highly accurate results. The method is highly suitable for analysis of single nucleotide polymorphism and sequencing of small fragment of DNA. Pyro sequencing techniques consist of series of sequential steps for detection
Next-generation Sequencing Market
Next-generation sequencing or high throughput sequencing are advanced DNA sequencing technologies, including Illumina (Solexa) sequencing, Roche 454 sequencing, and Ion torrent: Proton/ PGM sequencing, SOLiD sequencing. Next-generation sequencing technologies have a number of advantages such as high speed, flexibility, high throughput, and reduced sequencing cost. Next-generation sequencing has ability to produce terabytes of nucleotide sequence data in a lone sequencing procedure. The NGS technology is developing at a rapid rate,